Daten werden ergänzt – lade die Seite später neu, um den aktuellen Stand zu sehen
10487-86-2C[C@@H]1C[C@H]1C(=O)OAYEGPMGNMOIHDL-QWWZWVQMSA-N10487-86-2、6202-94-4DTXSID901242652Sicherheitsangaben dienen nur zur Orientierung und ersetzen weder das Sicherheitsdatenblatt (SDB) des Lieferanten noch geltende Vorschriften oder eine fachliche Bewertung.
Warning
H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral]
P261, P264, P264+P265, P270, P271, P280, P301+P317, P302+P352, P304+P340, P305+P351+P338, P317, P319, P321, P330, P332+P317, P337+P317, P362+P364, P403+P233, P405, and P501 (click each P-code to see the statement)
Aggregated GHS information provided per 2 reports by companies from 2 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.
Warning
H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral]
Acute Tox. 4 (100%)
Acute Tox. 4 (100%)
Verwenden(1R,2R)-2-Methylcyclopropanecarboxylic Acid, is an intermediate used for the synthesis of (1R,2R)-trans-1-(Chloromethyl)-2-methylcyclopropane (C369820). It can also be used for the preparation of Luzopeptin A-C and Quinoxapeptin A-C, acting as potent inhibitors of HIV-1 reverse transcriptase.